Summary:
- This article discusses the potential benefits of a new drug called semaglutide for treating obesity in adults. Semaglutide is a type of medication called a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate appetite and blood sugar levels.
- The study found that participants who received semaglutide lost an average of 15% of their body weight over 68 weeks, compared to those who received a placebo (inactive treatment) who only lost about 2.4% of their body weight.
- The study suggests that semaglutide could be an effective treatment option for adults struggling with obesity, as it can help them lose a significant amount of weight and potentially improve their overall health.